Literature DB >> 6350474

Treatment of herpes labialis.

A P Fiddian, J M Yeo, A E Clark.   

Abstract

Untreated herpes labialis may take up to 10 days or more to heal and antiviral therapy must be initiated early if it is to be effective. Acyclovir ointment has been reported to have an antiviral effect but no clinical benefit and a newer formulation, acyclovir cream, has been developed in an attempt to enhance skin penetration. In placebo-controlled trials, acyclovir cream shortened the duration of lesions significantly and when therapy was started before vesicles developed, the number of lesions aborting was increased significantly. This therapy was well tolerated by most patients. Topical acyclovir offers hope for the successful management of herpes labialis where systemic therapy is considered inappropriate.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6350474     DOI: 10.1016/s0163-4453(83)94118-x

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  3 in total

1.  Failure of acyclovir cream in treatment of recurrent herpes labialis.

Authors:  M Shaw; M King; J M Best; J E Banatvala; J R Gibson; M R Klaber
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-06

2.  Development of novel microemulsion-based topical formulations of acyclovir for the treatment of cutaneous herpetic infections.

Authors:  Sunita Rajan
Journal:  AAPS PharmSciTech       Date:  2009       Impact factor: 3.246

Review 3.  Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  J J O'Brien; D M Campoli-Richards
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.